YQ

Yimin Qian

AB Accutar Biotechnology: 6 patents #3 of 8Top 40%
AO Arvinas Operations: 4 patents #3 of 13Top 25%
YU Yale University: 1 patents #23 of 182Top 15%
📍 Plainsboro, NJ: #2 of 176 inventorsTop 2%
🗺 New Jersey: #86 of 6,720 inventorsTop 2%
Overall (2022): #7,469 of 548,613Top 2%
10
Patents 2022

Issued Patents 2022

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
11535606 Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof Jie Fan, Wei He, Ke Liu 2022-12-27
11530222 Substituted pyrrolopyrimidine and pyrazolopyrimidine as Bruton's tyrosine kinase (BTK) degraders Wei He, Robert Zhiyong Luo, Jie Su, Hui Zhang, Ke Liu +1 more 2022-12-20
11512083 Compounds and methods for the enhanced degradation of targeted proteins Andrew P. Crew, Craig M. Crews, Xin Chen, Hanqing Dong, Caterina Ferraro +5 more 2022-11-29
11427548 Compounds and methods for the targeted degradation of androgen receptor Andrew P. Crew, Hanqing Dong, Jing Wang, Xin Chen, Kurt Zimmermann +2 more 2022-08-30
11420956 Ureas having Androgen Receptor degradation activity and uses thereof Jie Fan, Wei He, Ke Liu 2022-08-23
11384063 Modulators of estrogen receptor proteolysis and associated methods of use Andrew P. Crew, Hanqing Dong, Jing Wang 2022-07-12
11352351 Compounds and methods for the targeted degradation of androgen receptor Meizhong Jin, Andrew P. Crew, Hanqing Dong, Jing Wang, Xin Chen 2022-06-07
11312702 Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof Jie Fan, Wei He, Ke Liu 2022-04-26
11261178 Chroman derivatives having estrogen receptor degradation activity and uses thereof Jie Fan, Wei He, Ke Liu 2022-03-01
11220490 Ureas having androgen receptor degradation activity and uses thereof Jie Fan, Wei He, Ke Liu 2022-01-11